**Core tip:** This was a retrospective study to clarify the relationship between neutrophil-to-lymphocyte ratio (NLR) and the occurrence of acute kidney injury (AKI) in patients with gastrointestinal and hepatobiliary surgery in the surgical intensive care unit (ICU). We found that patients with NLR ≥ 8.380 exhibited significantly higher incidences of postoperative AKI and severe AKI. NLR at admission is a predictor of AKI in patients with gastrointestinal and hepatobiliary surgery in ICU. We recommend that NLR should be included in the routine assessment of AKI occurrence.

INTRODUCTION
============

Acute kidney injury (AKI) is one of the most common complications after gastrointestinal and hepatobiliary surgery. Numerous studies have reported high incidences of postoperative AKI, ranging from 22% to 66% in intensive care unit (ICU)\[[@B1]-[@B4]\]. Postoperative AKI and its stages are independent risk factors for the prognosis of surgical patients\[[@B5]\]. In addition, a large number of studies have reported that AKI significantly increases the risk of chronic renal insufficiency and end-stage kidney disease\[[@B6],[@B7]\]. Patients with severe AKI often require renal replacement therapy, and once developed into end-stage kidney disease, patients would require long-term hemodialysis, which decreases quality of life\[[@B8]\]. Early detection of AKI is critical to the treatment of perioperative patients. Serum creatinine is a classic indicator of AKI, but changes in serum creatinine levels often occur at a later stage. Some new tests are either too expensive or too difficult to implement, making them difficult for clinical use\[[@B9]\]. Therefore, indicators that can predict the occurrence of AKI after surgery are urgently needed.

The neutrophil-to-lymphocyte ratio (NLR) is a marker of inflammation that can be calculated directly from a patient\'s complete blood count. Extensive studies have shown that NLR can predict the outcome of cardiac surgery, sepsis, and cancer\[[@B10]-[@B13]\]. A recent study showed that sepsis patients with NLR \> 17.11 were more likely to develop AKI\[[@B10]\]. The risk factors and early diagnosis of postoperative AKI have always been urgent problems in clinic. Nevertheless, whether NLR at admission can predict the occurrence of AKI after surgery in patients receiving ICU care remains unknown. We hypothesize that NLR is an independent risk factor for AKI after surgery, and patients with high NLR are more likely to develop postoperative AKI. The main purpose of this article was to clarify the relationship between NLR and the occurrence of postoperative AKI in patients with gastrointestinal and hepatobiliary surgery in the ICU.

MATERIALS AND METHODS
=====================

Patients and data sources
-------------------------

This study retrospectively analyzed the electronic medical records of 282 patients after gastrointestinal and hepatobiliary surgery in the ICU of the First Affiliated Hospital of Xi'an Jiaotong University from December 2014 to December 2018. The inclusion criteria were: Patients admitted to the ICU after gastrointestinal or hepatobiliary surgery; aged over 18 years; hospitalized in the ICU for at least 24 hours. The exclusion criteria were: Patients admitted with known acute or chronic kidney disease; patients with liver transplantation; patients without complete clinical data. This study complied with the provisions of Declaration of Helsinki\[[@B14]\]. The protocol was approved by the Ethics Committee of the First Affiliated Hospital of Xi\'an Jiaotong University.

Definition of clinical outcome
------------------------------

The clinical outcomes in this study included occurrence of AKI and severe AKI, length of ICU stay, ICU re-admission, ICU mortality and 28-day overall mortality. The definition of AKI complied with Kidney Disease: Improving Global Outcomes criteria\[[@B15]\] as follows: The serum creatinine level increased by ≥ 0.3 mg/dL (≥ 26 mmol/L) within 48 h, or serum creatinine levels increased by 1.5 times of the baseline within 7 d after surgery, or urine volume was less than 0.5mL/kg per h and lasted more than 6 h. The staging of AKI is defined as follows: Stage 1, serum creatinine level increased by ≥ 0.3 mg/dL (≥ 26 mmol/L) within 48 h, or serum creatinine levels increased by 1.5-1.9 times of the baseline within 7 d after surgery; Stage 2, serum creatinine serum creatinine levels increased by 2.0-2.9 times of the baseline within 7 d after surgery; Stage 3, serum creatinine level increased by ≥ 4.0 mg/dL (≥ 354 mmol/L) within 48 h, or serum creatinine levels increased by more than 3.0 times of the baseline within 7 d after surgery, or patients require renal replacement therapy. Severe AKI is defined as AKI of stage 2 and 3.

Statistical analysis
--------------------

The distribution of the continuous variables was checked for normality using the Kolmogorov-Smirnov test. Normally distributed variables were expressed as mean ± SD, and differences between the two groups were analyzed by the *t* test. Nonnormally distributed variables were expressed as medians (interquartile range) and differences between the two groups were analyzed by the Mann-Whitney. Categorical variables were expressed as absolute numbers and percent frequencies and differences between the two groups were analyzed by *χ*^2^ or Fisher's exact test. Univariate and multivariate analyses were performed using logistic regression models. Variables with *P* \< 0.05 in the univariate analysis were incorporated into the multivariate analysis. The receiver operating characteristic (ROC) curve was used to determine the optimal cut-off value (with the highest sum of specificity plus sensitivity). PASW 18.0 software (SPSS Inc., Chicago, Illinois, United States) was used for statistical analysis. A two-tailed *P* \< 0.05 was considered statistically significant.

RESULTS
=======

Risk factors for postoperative AKI in patients with gastrointestinal and hepatobiliary surgery in ICU
-----------------------------------------------------------------------------------------------------

A total of 84 patients (29.79%) developed postoperative AKI in this cohort. To identify risk factors for AKI in patients with gastrointestinal and hepatobiliary surgery in ICU, univariate and multivariate analyses were performed (Table [1](#T1){ref-type="table"}). The results of univariate analysis exhibited that the following factors were significantly associated with occurrence of AKI in patients with gastrointestinal and hepatobiliary surgery in ICU, including sex (HR: 1.761, 95%CI: 1.008-3.075, *P* = 0.047), drinking (HR: 0.547, 95%CI: 0.306-0.977, *P* = 0.042), coexisting condition of ischemic heart disease (HR: 0.387, 95%CI: 0.166-0.901, *P* = 0.028), sequential organ failure assessment score (SOFA score) at ICU admission (HR: 1.092, 95%CI: 1.030-1.157, *P* = 0.003), acute physiology and chronic health evaluation (APACHE II) at ICU admission (HR: 1.038, 95%CI: 1.005-1.073, *P* = 0.023), serum creatinine (HR: 1.005, 95%CI: 1.003-1.007, *P* \< 0.001), serum K concentration (HR: 1.676, 95%CI: 1.190-2.362, *P* = 0.003) and NLR (HR: 1.052, 95%CI: 1.026-1.078, *P* \< 0.001). Further multivariate analysis revealed that NLR (HR: 1.290, 95%CI: 1.212-1.373, *P* \< 0.001) was an independent risk factor for occurrence of postoperative AKI in patients with gastrointestinal and hepatobiliary surgery in ICU.

###### 

Risk factors of acute kidney injury occurrence by univariate and multivariate analyses

  **Parameters**                                     **Univariate analysis**   **Multivariate analysis**                         
  -------------------------------------------------- ------------------------- --------------------------- --------------------- ----------
  Age ( \< 65 yr/≥ 65 yr)                            1.010 (0.996-1.024)       0.146                       \-                    \-
  Sex (male/femal)                                   1.761 (1.008-3.075)       0.047                       0.684 (0.325-1.438)   0.316
  Smoking (yes/no)                                   0.599 (0.351-1.021)       0.060                       \-                    \-
  Drinking (yes/no)                                  0.547 (0.306-0.977)       0.042                       0.916 (0.401-2.097)   0.836
  MAP (mmHg)                                         1.001 (0.988-1.014)       0.923                                             
  Hypertension (yes/no)                              1.218 (0.668-2.223)       0.519                       \-                    \-
  Diabetes mellitus (yes/no)                         0.828 (0.393-1.744)       0.619                       \-                    \-
  Cirrhosis (yes/no)                                 0.563 (0.239-1.324)       0.188                       \-                    \-
  Ischemic heart disease (yes/no)                    0.387 (0.166-0.901)       0.028                       1.111 (0.385-3.212)   0.845
  Stroke (yes/no)                                    2.500 (0.834-7.493)       0.102                       \-                    \-
  Malignant diseases (yes/no)                        0.949 (0.514-1.751)       0.867                       \-                    \-
  SOFA score at ICU admission                        1.092 (1.030-1.157)       0.003                       1.010 (0.937-1.088)   0.801
  APACHE II at ICU admission                         1.038 (1.005-1.073)       0.023                       1.006 (0.954-1.060)   0.836
  PLT (10^9^/L)                                      0.999 (0.997-1.002)       0.487                       \-                    \-
  WBC (10^9^/L)                                      1.026 (0.999-1.055)       0.062                       \-                    \-
  TB                                                 1.001 (0.999-1.003)       0.216                                             
  Creatinine                                         1.005 (1.003-1.007)       \< 0.001                    1.000 (0.998-1.002)   0.989
  K                                                  1.676 (1.190-2.362)       0.003                       0.918 (0.594-1.416)   0.698
  Na                                                 1.012 (0.979-1.046)       0.473                       \-                    \-
  INR                                                1.269 (0.980-1.641)       0.070                       \-                    \-
  PaO~2~/FiO~2~                                      0.994 (0.883-1.119)       0.920                       \-                    \-
  Arterial lactate[1](#T1FN1){ref-type="table-fn"}   0.936 (0.876-1.000)       0.051                                             
  Procalcitonin[2](#T1FN2){ref-type="table-fn"}      1.003 (0.096-1.011)       0.348                       \-                    \-
  Blood transfusion (yes/no)                         0.898 (0.555-1.452)       0.660                       \-                    \-
  NLR                                                1.052 (1.026-1.078)       \< 0.001                    1.290 (1.212-1.373)   \< 0.001

High neutrophil to lymphocyte ratio (NLR) group (*n* = 167), Low NLR group (*n* = 89).

High NLR group (*n* = 154), Low NLR group (*n* = 79). HR: Hazard ratio; MAP: Mean arterial pressure; SOFA score: Sequential organ failure assessment score; APACH II: Acute physiology and chronic health evaluation; PLT: Platelet count; WBC: White blood cell count; TB: Total bilirubin; INR: International normalized ratio; PaO~2~/FiO~2~: Oxygen partial pressure/oxygen concentration; NLR: Neutrophil to lymphocyte ratio.

ROC curve analysis
------------------

ROC curves analysis with occurrence of AKI was used to determine the optimal cut-off value of NLR. The value of NLR at the maximum value of the Youden index is taken as the optimal cut-off point. As shown in Figure [1](#F1){ref-type="fig"}, the optimal cut-off value of NLR was 8.380 \[sensitivity of 82.14% and specificity of 43.43%, area under the curve = 0.634, 95%CI: 0.563-0.705, *P* = 0.0004\]. The patients were divided into a high-NLR group (*n* = 181) and a low-NLR group (*n* = 101) by the optimal cut-off value of NLR (8.380).

![Receiver operating characteristic analysis for optimal cutoff values of neutrophil-to-lymphocyte ratio. Area under the receiver operating characteristic curve: 0.6338. The optimal cutoff value of neutrophil-to-lymphocyte ratio was 8.38. NLR: Neutrophil-to-lymphocyte ratio; ROC: Receiver operating characteristic.](WJGS-12-326-g001){#F1}

Patient demographics and clinical features of the high and low NLR groups
-------------------------------------------------------------------------

As shown in Table [2](#T2){ref-type="table"}, the average age of 282 patients in ICU was 60.48 ± 17.74 years. In the cohort, 24.11% of patients underwent hepatobiliary surgery. The age, sex, operative site and characteristics of surgery showed no significant differences between the high-NLR and low-NLR groups. Laboratory examination at ICU admission revealed that the high-NLR group exhibited higher white blood cell count (14.85 ± 10.25 *vs* 8.77 ± 5.65, *P* \< 0.001) and neutrophil count (13.10 ± 7.91 *vs* 6.34 ± 4.32, *P* \< 0.001), and lower lymphocyte count (0.78 ± 0.50 *vs* 1.49 ± 1.50, *P* \< 0.001) and arterial lactate (2.91 ± 3.29 *vs* 4.40 ± 5.23, *P* = 0.006) than the low-NLR group. No significant differences were found in SOFA and APACHE II scores at ICU admission between the two groups. The most common coexisting conditions at ICU admission were smoking, hypertension and drinking. There were no differences in smoking, hypertension, drinking, diabetes mellitus, ischemic heart disease, stroke, and malignant diseases between the high and low-NLR patients. There was no significant difference in terms of ICU care, including ventilation, steroids, cardio-pulmonary resuscitation, vasopressor and transfusion, except that high-NLR patients used more dialysis.

###### 

Patient demographics and clinical features of the high and low NLR groups

  **Variables**                                               **Overall** **(*n* = 282)**   **High-NLR group (*n* = 181)**   **Low-NLR group (*n* = 101)**   ***P* value**
  ----------------------------------------------------------- ----------------------------- -------------------------------- ------------------------------- ---------------
  Age (yr)                                                    60.48 ± 17.74                 62.62 ± 17.44                    58.42 ± 18.17                   0.146
  Sex (male/female)                                           180/102                       114/67                           66/35                           0.695
  Operative site                                                                                                                                             0.330
  Gastrointestinal surgery, *n* (%)                           214 (75.89)                   134 (74.03)                      80 (79.21)                      
  Hepatobiliary surgery, *n* (%)                              68 (24.11)                    47 (25.97)                       21 (20.79)                      
  Characteritics of surgery                                                                                                                                  0.398
  Emergency surgery                                           55 (19.5)                     38 (21.0)                        17 (16.8)                       
  Non-emergency surgery                                       227 (80.5)                    143 (79.0)                       84 (83.2)                       
  Lab values at ICU admission                                                                                                                                
  PLT (10^9^/L)                                               144.17 ± 112.61               146.84 ± 114.94                  139.40 ± 108.70                 0.596
  WBC (10^9^/L)                                               12.67 ± 9.34                  14.85 ± 10.25                    8.77 ± 5.65                     \< 0.001
  ALT (U/L)                                                   169.28 ± 356.37               194.10 ± 413.23                  126.53 ± 259.71                 0.140
  AST (U/L)                                                   258.83 ± 683.02               310.81 ± 822.44                  169.28 ± 308.64                 0.098
  TB (μmol/L)                                                 87.42 ± 132.18                90.95 ± 126.59                   81.14 ± 142.01                  0.554
  Albumin (g/L)                                               28.63 ± 6.42                  28.14 ±5.90                      29.49 ± 7.20                    0.091
  Creatinine (μmol/L)                                         131.44 ± 135.27               138.84 ± 122.81                  118.20 ± 154.87                 0.225
  K (mmol/L)                                                  3.95 ± 0.76                   4.03 ± 0.77                      3.82 ± 0.73                     0.034
  Na (mmol/L)                                                 137.55 ± 7.72                 137.68 ± 7.54                    137.32 ± 8.05                   0.708
  Neutrophil (10^9^/L)                                        10.68 ± 7.57                  13.10 ± 7.91                     6.34 ± 4.32                     \< 0.001
  Lymphocyte (10^9^/L)                                        1.04 ± 1.04                   0.78 ± 0.50                      1.49 ± 1.50                     \< 0.001
  PaO~2~/FiO~2~                                               3.24 ± 2.08                   3.30 ± 1.75                      3.14 ± 2.63                     0.576
  Arterial lactate (mmol/L)[1](#T2FN1){ref-type="table-fn"}   3.43 ± 4.13                   2.91 ± 3.29                      4.40 ± 5.23                     0.006
  Procalcitonin (ng/mL)[2](#T2FN2){ref-type="table-fn"}       15.85 ± 35.73                 17.11 ± 39.68                    13.37 ± 26.29                   0.453
  SOFA score at ICU admission                                 7.74 ± 5.01                   7.63 ± 4.11                      7.93 ± 6.34                     0.806
  APACHE II at ICU admission                                  16.04 ± 7.78                  15.95 ± 7.49                     16.19 ± 8.31                    0.630
  Coexisting conditions                                                                                                                                      
  Smoking (yes/no)                                            91/191                        60/121                           31/70                           0.672
  Drinking (yes/no)                                           65/217                        43/138                           22/79                           0.706
  Hypertension (yes/no)                                       71/211                        44/137                           27/74                           0.653
  Diabetes mellitus (yes/no)                                  36/246                        27/154                           9/92                            0.147
  Ischemic heart disease (yes/no)                             24/258                        16/165                           8/93                            0.791
  Stroke (yes/no)                                             26/256                        15/166                           11/90                           0.469
  Malignant diseases (yes/no)                                 62/220                        43/138                           19/82                           0.336
  ICU care                                                                                                                                                   
  Ventilation (yes/no)                                        169/113                       103/78                           66/35                           0.166
  Dialysis (yes/no)                                           72/210                        54/127                           18/83                           0.027
  Steroids (yes/no)                                           81/201                        52/129                           29/72                           0.998
  CPR (yes/no)                                                58/224                        35/146                           23/78                           0.494
  Vasopressor (yes/no)                                        131/151                       84/97                            47/54                           0.984
  Transfusion                                                 173/109                       112/69                           61/40                           0.806

High neutrophil to lymphocyte ratio (NLR) group: NLR ≥ 8.380, Low NLR group: NLR \< 8.380.

High NLR group (*n* = 167), Low NLR group (*n* = 89).

High NLR group (*n* = 154), Low NLR group (*n* = 79). WBC: White blood cell count; PLT: Platelet count; ALT: Alanine aminotransferase; AST: Alanine aminotransferase; PaO~2~/FiO~2~: Oxygen partial pressure/oxygen concentration; APACHE II: Acute physiology and chronic health evaluation; SOFA score: Sequential organ failure assessment score; CPR: Cardio-pulmonary resuscitation; NLR: Neutrophil-to-lymphocyte ratio.

NLR levels in AKI and non-AKI patients
--------------------------------------

To further clarify the relationship between postoperative AKI occurrence and NLR, we analyzed the NLR levels in the AKI patients and non-AKI patients. The results showed that AKI patients had higher NLR value compared with the non-AKI patients (18.210 ± 14.179 *vs* 12.121 ± 8.499, *P* \< 0.001) (Figure [2A](#F2){ref-type="fig"}). Additionally, NLR increased with the severity of AKI (stage 1: 17.356 ± 15.686, stage 2: 19.697 ± 5.080, stage 3: 20.113±13.937) and was significantly higher in all three stages than that in the non-AKI group (Figure [2B](#F2){ref-type="fig"}).

![Neutrophil-to-lymphocyte ratio in acute kidney injury and non-acute kidney injury patients. ^a^*P* \< 0.05 *vs* non-AKI group. NLR: Neutrophil-to-lymphocyte ratio; AKI: Acute kidney injury.](WJGS-12-326-g002){#F2}

Clinical outcomes of patients with high and low NLR levels
----------------------------------------------------------

Clinical outcomes of patients in the high and low NLR groups are shown in Table [3](#T3){ref-type="table"}. A total of 84 patients (29.79%) and 28 patients (9.92%) were complicated with AKI and severe AKI, respectively. The incidence of AKI and severe AKI in the high-NLR group was significantly higher than those in the low-NLR group (AKI: 38.12% *vs* 14.85%, *P* \< 0.001; severe AKI: 14.36% *vs* 1.98%, *P* = 0.001). The difference in the occurrence of sepsis between two groups showed a strong tendency of statistical significance (17.68% *vs* 10.89%, *P* = 0.083). Additionally, length of ICU stays, ICU re-admission, ICU mortality and 28-d overall mortality exhibited no significant differences between the high-NLR and low-NLR groups.

###### 

Clinical outcomes of the high and low NLR groups

  **Variables**                                                **Overall (*n* = 282)**   **High-NLR group (*n* = 181)**   **Low-NLR group (*n* = 101)**   ***P* value**
  ------------------------------------------------------------ ------------------------- -------------------------------- ------------------------------- ---------------
  Renal                                                                                                                                                   
  AKI, *n* (%)                                                 84 (29.79)                69 (38.12)                       15 (14.85)                      \< 0.001
  Severe AKI                                                   28 (9.92)                 26 (14.36)                       2 (1.98)                        0.001
  Sepsis, *n* (%)                                              45 (15.96)                32 (17.68)                       11 (10.89)                      0.083
  Length of ICU stay (d)                                       11.36 ± 13.37             11.36 ± 12.58                    11.38 ± 14.74                   0.990
  ICU re-admission, *n* (%)                                    40 (14.18)                24 (13.25)                       16 (15.84)                      0.551
  ICU mortality, *n* (%)                                       41 (14.54)                24 (13.25)                       17 (16.83)                      0.415
  28-d overall mortality (%)[1](#T3FN1){ref-type="table-fn"}   80 (28.4)                 55 (30.4)                        25 (24.8)                       0.314

High neutrophil to lymphocyte ratio (NLR) group: NLR ≥ 8.380, Low NLR group: NLR \< 8.380; Severe AKI: AKI of stage 2 and stage 3.

28-d overall mortality included ICU mortality and 28-d mortality after leaving ICU. AKI: Acute kidney injury; ICU: Intensive care unit.

DISCUSSION
==========

In this study, the multivariate analysis showed NLR at admission was an independent risk factor for occurrence of postoperative AKI in patients with gastrointestinal and hepatobiliary surgery in ICU. Patients with NLR ≥ 8.380 exhibited significantly higher incidences of postoperative AKI and severe AKI. NLR at admission could be a predictor of AKI occurrence in patients with gastrointestinal and hepatobiliary surgery and should be included in the routine assessment of AKI occurrence.

AKI is one of the most common critical illnesses with high morbidity and poor prognosis. The causes of AKI are extremely complicated, including renal hypoperfusion such as hypovolemia and reduced cardiac output, nephrotoxicity drugs and urinary obstruction\[[@B16]\]. Different causes eventually lead to hypoxia, inflammation, oxidative stress and innate immune system activation and cell death\[[@B17]\]. AKI is a common complication after abdominal surgery. The mortality of patients with postoperative AKI after abdominal surgery increased by 3.5 times\[[@B18]\]. A large number of previous studies have shown that preoperative renal insufficiency is the most important risk factor for AKI after abdominal surgery, and other risk factors include preoperative dehydration, intra-abdominal hypertension, blood transfusion, and use of nephrotoxic drug\[[@B19]\]. Our study found a 29.79% incidence of postoperative AKI in patients with gastrointestinal and hepatobiliary surgery in ICU. Univariate analysis exhibited that sex, coexisting condition of ischemic heart disease, SOFA score at ICU admission, APACHE II at ICU admission, serum creatinine, serum K concentration and NLR were significantly associated with occurrence of postoperative AKI. However, multivariate analysis revealed that only NLR was the independent risk factor for occurrence of postoperative AKI in surgical ICU.

Intrarenal and systemic response plays a key role in postoperative AKI. A large number of inflammatory factors and inflammatory cells promote oxidative stress and apoptosis, eventually leading to renal insufficiency\[[@B20]\]. Many anti-inflammatory drugs have significant effects on AKI and have entered clinical trials\[[@B20]\]. Early detection of AKI has great influence on the prognosis of postoperative patients. Examinination of indicators of renal insufficiency, such as creatinine and urea nitrogen, is the most accurate test, but changes often occur at a later stage\[[@B21]\]. Some new tests are either too expensive or too difficult to implement, making them difficult for clinical use\[[@B9]\]. NLR is a marker of inflammation reflecting the progress of inflammation-related disease. Extensive studies have shown that NLR can predict the outcome of cardiac surgery, sepsis, and cancer\[[@B10]-[@B12]\]. Our study showed that NLR at admission was an independent risk factor for occurrence of postoperative AKI and patients with NLR ≥ 8.380 exhibited significantly higher incidences of postoperative AKI and severe AKI. NLR, characterized by easy accessibility, objectivity, and noninvasiveness, could be a better predictor of AKI occurrence in patients with gastrointestinal and hepatobiliary surgery.

Sepsis is life threatening organ dysfunction caused by the host\'s harmful response to infection. Patients with AKI significantly increased sepsis mortality\[[@B22]\]. Studies have shown that sepsis is associated with 50% of AKI, and up to 60% of sepsis patients develop organ dysfunction including AKI\[[@B23]\]. Mechanism of sepsis-induced AKI is that deleterious inflammatory cascade of sepsis causes kidney damage\[[@B10],[@B24]\]. Several studies have shown that NLR is a predictor of AKI occurrence in patients with sepsis. They showed that NLR ≥ 9.11 in sepsis had a high risk of AKI occurrence\[[@B24]\]. In this study, the difference in the occurrence of sepsis between high-NLR group and low-NLR group showed a strong tendency of statistical significance (17.68% *vs* 10.89%, *P* = 0.083). The high tendency of sepsis in the NLR ≥ 8.380 group may be one of the important reasons for NLR as an independent risk factor for AKI in patients with gastrointestinal and hepatobiliary surgery in ICU.

High levels of arterial lactate reflect tissue microcirculatory insufficiency. Numerous studies have considered lactic acid levels as a risk factor in critically ill patients\[[@B25],[@B26]\]. However, in this study, the multivariate analysis showed that arterial lactate at admission was not an independent risk factor for occurrence of postoperative AKI in patients with gastrointestinal and hepatobiliary surgery in ICU. Intraoperative tissue ischemia and postoperative coagulation and sepsis may lead to changes in lactate levels\[[@B27]\]. In addition, severe inflammatory response in the tissue can lead to elevated lactic acid levels\[[@B28]\]. Our study showed that patients with NLR ≥ 8.380 had high arterial lactate levels (2.91 ± 3.29 mmol/L *vs* 4.40 ± 5.23 mmol/L, *P* = 0.006). Increased lactic acid levels may be due to postoperative inflammation under such conditions.

This study has several limitations. First, this is a single-center retrospective cohort study. The results might be influenced by selection bias, recall bias and some residual confounding. A further multiple-center data was needed to clarify the relationship between NLR and the occurrence of AKI in patients with gastrointestinal and hepatobiliary surgery in ICU. Second, this study retrospectively analyzed the electronic medical records of 282 patients after gastrointestinal and hepatobiliary surgery in the surgical ICU. The conclusion is only based on a small number of patients. A further large sample sized study is needed in the future. Additionally, this research mainly clarified the phenomenon that NLR at admission is a predictor of AKI occurrence, and the specific mechanism needs further study.

In conclusion, NLR at admission was an independent risk factor and could be a predictor for occurrence of postoperative AKI in patients with gastrointestinal and hepatobiliary surgery in ICU. NLR should be included in the routine assessment of AKI occurrence.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Postoperative acute kidney injury (AKI) is one of the most common complications after gastrointestinal and hepatobiliary surgery. Neutrophil-to-lymphocyte ratio (NLR) is a marker of inflammation that can be calculated directly from a patient\'s complete blood count. Extensive studies have shown that NLR can predict the outcome of cardiac surgery, sepsis, and cancer.

Research motivation
-------------------

The risk factors and early diagnosis of postoperative AKI have always been urgent problems in clinic.

Research objectives
-------------------

To clarify the relationship between NLR and the occurrence of AKI in patients with gastrointestinal and hepatobiliary surgery in the intensive care unit (ICU).

Research methods
----------------

This study retrospectively analyzed the electronic medical records of 282 patients after gastrointestinal and hepatobiliary surgery in ICU to clarify the relationship between NLR at admission and the postoperative AKI occurrence.

Research results
----------------

Postoperative AKI occurred in 29.79% of patients receiving ICU care. NLR value at admission was higher in AKI patients compared with the non-AKI patients and increased with the severity of AKI. Patients with NLR ≥ 8.380 exhibited significantly higher incidences of postoperative AKI and severe AKI than patients with NLR \< 8.380. The multivariate analysis showed that NLR at admission was an independent risk factor for occurrence of postoperative AKI in patients with gastrointestinal and hepatobiliary surgery in ICU.

Research conclusions
--------------------

NLR at admission is a predictor of AKI occurrence in patients with gastrointestinal and hepatobiliary surgery in ICU.

Research perspectives
---------------------

NLR should be included in the routine assessment of AKI occurrence.
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